Cambridge Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $250K | Sell |
|
|||||
|
2025
Q2 | $272K | Hold |
|
|||||
|
2025
Q1 | $275K | Hold |
|
|||||
|
2024
Q4 | $226K | Sell |
|
|||||
|
2024
Q3 | $222K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $215K | Sell |
|
|||||
|
2023
Q3 | $232K | Hold |
|
|||||
|
2023
Q2 | $238K | Hold |
|
|||||
|
2023
Q1 | $256K | Hold |
|
|||||
|
2022
Q4 | $265K | Sell |
|
|||||
|
2022
Q3 | $647K | Buy |
|
|||||
|
2022
Q2 | $642K | Sell |
|
|||||
|
2022
Q1 | $630K | Sell |
|
|||||
|
2021
Q4 | $810K | Sell |
|
|||||
|
2021
Q3 | $793K | Hold |
|
|||||
|
2021
Q2 | $782K | Sell |
|
|||||
|
2021
Q1 | $754K | Buy |
|
|||||
|
2020
Q4 | $534K | Sell |
|
|||||
|
2020
Q3 | $593K | Sell |
|
|||||
|
2020
Q2 | $735K | Buy |
|
|||||
|
2020
Q1 | $656K | Buy |
|
|||||
|
2019
Q4 | $482K | Sell |
|
|||||
|
2019
Q3 | $473K | Sell |
|
|||||
|
2019
Q2 | $525K | Sell |
|
|||||
|
2019
Q1 | $553K | Sell |
|
|||||
|
2018
Q4 | $536K | Sell |
|
|||||
|
2018
Q3 | $742K | Sell |
|
|||||
|
2018
Q2 | $702K | Sell |
|
|||||
|
2018
Q1 | $759K | Buy |
|
|||||
|
2017
Q4 | $492K | Sell |
|
|||||
|
2017
Q3 | $559K | Hold |
|
|||||
|
2017
Q2 | $488K | Sell |
|
|||||
|
2017
Q1 | $495K | Sell |
|
|||||
|
2016
Q4 | $532K | Sell |
|
|||||
|
2016
Q3 | $664K | Sell |
|
|||||
|
2016
Q2 | $729K | Sell |
|
|||||
|
2016
Q1 | $828K | Buy |
|
|||||
|
2015
Q4 | $896K | Buy |
|
|||||
|
2015
Q3 | $796K | Buy |
|
|||||
|
2015
Q2 | $943K | Buy |
|
|||||
|
2015
Q1 | $1.16M | Sell |
|
|||||
|
2014
Q4 | $806K | Buy |
|